| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |